-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Many common factors in chronic diseases, such as fatigue and depression, affect cognitive dysfunction (CD), but the impact of systemic lupus erythematosus (SLE) disease activity on CD is unclear.
The study selected two groups of patients with systemic lupus erythematosus: stable phase/low activity phase (SLE-S, n = 36 cases) and active phase (SLE-F, n = 26 cases).
Analysis of BOLD signal difference during n-back task between SLE-S and SLE-Fv1
Analysis of BOLD signal difference during n-back task between SLE-S and SLE-Fv1
Changes of BILAG scores in SLE-F group twice
Changes of BILAG scores in SLE-F group twiceWhen using the CANTAB® test, no differences were found between the two groups.
Many factors affect the cognitive function of SLE.
Many factors affect the cognitive function of SLE.
oup.
oup.
com/rheumatology/advance-article-abstract/doi/10.
1093/rheumatology/keab256/6184875?redirectedFrom=fulltext" target="_blank" rel="noopener">Barraclough, Michelle et al.
“The effects of disease activity on neuronal and behavioural cognitive processes in systemic lupus erythematosus.
”Rheumatology (Oxford, England) , keab256.
24 Mar.
2021, doi:10.
1093/rheumatology/keab256 Barraclough, Michelle et al "The effects of disease activity on neuronal and behavioural cognitive processes in systemic lupus erythematosus.
"Rheumatology (Oxford, England) leave a message here